On May 27, 2021 SOM Biotech reported its participation in the BIO International Convention 2021 on June 10th – 18th, that will take place digitally (Press release, SOM Biotech, MAY 27, 2021, View Source;utm_medium=rss&utm_campaign=som-at-the-bio-international-convention-2021 [SID1234580679]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Hosted by the Biotechnology Innovation Organisation, the event is the largest global event for the biotechnology industry that attracts the leading biotech companies, scientists, research institutions, advisors, and qualified investors, providing extensive networking and partnering platform to support innovation, investment, and value creation.

Raúl Insa, CEO of SOM Biotech highlights: "The BIO International Convention is a key event to meet high profile partners and investors to explore areas of common interest and foster drug development initiatives and innovation. SOM Biotech is achieving outstanding results with its proprietary AI- ligand-based drug discovery platform, which we´d like to share with investors and potential business partners. Our unique technology has enabled us to build a robust drug development pipeline for orphan/CNS drug candidates. The Convention is a great opportunity to engage in strong partnerships with pharma companies and to meet with qualified investors. We look forward to identifying and sharing new business opportunities with both to continue growing."